Department of Veterans Affairs Office of Inspector General Semiannual Report to Congress April Through September 2017

Total Page:16

File Type:pdf, Size:1020Kb

Department of Veterans Affairs Office of Inspector General Semiannual Report to Congress April Through September 2017 Department of Veterans Affairs Office of Inspector General Semiannual Report to Congress Issue 78 | April 1 – September 30, 2017 OIG MISSION To serve veterans and the public by conducting effective oversight of the programs and operations of the Department of Veterans Affairs (VA) through independent audits, inspections, and investigations. VISION To meet our mission and enhance the trust and confidence of veterans and their families, Veterans Service Organizations, Congress, VA employees, and the public, we must: Ensure that our work is independent and avoid any appearance of impairment to our independence. Prevent and detect fraud, waste, and abuse in VA programs and operations. Be proactive and strategic in identifying impactful issues. Produce reports that are: Accurate Timely Fair Objective Thorough Make meaningful recommendations that drive economy, efficiency, and effectiveness throughout VA programs and operations. Be fully transparent by promptly releasing reports that are not otherwise prohibited from disclosure. Promote accountability of VA employees if they fail to perform as expected. Attract, develop, and retain the highest quality staff in the Office of Inspector General (OIG). Treat whistleblowers and others who provide information to the OIG with respect and dignity and protect their identities if they so desire. VALUES Our conduct will be guided and informed by adherence to the following values: Meet the highest standards of professionalism, character, ethics, and integrity. Work as one organization by encouraging teamwork and collaboration across directorates and offices. Establish a positive and engaging work environment. Promote diversity, individual perspectives, and equal opportunity throughout the OIG. Respect the role and expertise that each staff member brings to the OIG. Continually improve our performance. Ensure equitable opportunities for professional growth and development. Accept responsibility for our behavior and performance. Message from the Inspector General I am pleased to submit this Semiannual Report to Congress that highlights our activities and accomplishments for the April 1 to September 30, 2017 reporting period. I believe this report refl ects VA Offi ce of Inspector General (OIG) staff’s strong commitment to ensuring that veterans receive the health care, benefi ts, and other services they have earned. In the past 6 months, we continued to make signifi cant enhancements to our organization to conduct more eff ective oversight of VA’s programs and operations. Th is includes advancing our collaborative eff orts to identify the underlying causes of problems and then produce timely, accurate, and high-quality reports. Our reports typically include recommendations to VA. Th ese recommendations are carefully developed to help improve effectiveness while preventing or redressing fraud, waste, abuse, and other misconduct. For example, we have launched a Rapid Response Team that draws on healthcare professionals, auditors, criminal investigators, and other experts across OIG to quickly respond to allegations of compromised patient safety. Th is team investigated allegations at the Washington, DC VA Medical Center (VAMC) and produced an Interim Report with recommendations for immediate action to reduce risks to patients and Federal Government assets. Although our work on the DC VAMC is not yet completed, improvements at the facility are already being implemented. OIG has expanded the inspection of the DC VAMC, and we are preparing a fi nal report with detailed recommendations. Meanwhile, the Rapid Response Team has deployed to other VA facilities where there is a critical need to assess imminent risk to veterans’ care. Another enhancement has been implementing the redesign of our Combined Assessment Program into the Comprehensive Healthcare Inspection Program. Unannounced OIG visits to facilities follow a newly developed protocol that examines high-risk areas and results in a more useful written review for facility and other VA leaders to make needed improvements. In addition to the Offi ce of Healthcare Inspections (OHI), other directorates also have been realigned to address key VA challenges. Finally, to better ensure OIG’s independence and transparency, we are now directing and funding the work of the Offi ce of Contract Review, which was previously supported through a reimbursable agreement with VA. Th ese and other changes have been made to advance OIG’s mission and values. In that spirit, we have also developed a new dashboard for our website that allows users to track both monetary impact and open recommendations associated with our reports. OIG issued 194 reports and work products on VA programs and operations during this reporting period. Th ose investigations, inspections, audits, evaluations, and other reviews identifi ed more than $9 billion in monetary impact, for a substantial return on investment of $134 for every dollar expended on OIG oversight. Approximately $5 billion of that amount is attributed to potential cost-savings OIG identified in relation to a Hepatitis C drug contract. Th e OIG Hotline received more than 20,000 contacts over 6 months from sources concerning VA programs and operations. OIG investigators closed 295 investigations and made 162 arrests for crimes including fraud, bribery, Semiannual Report to Congress | 1 Issue 78 | April 1–September 30, 2017 Message from the Inspector General embezzlement, identity theft, drug diversion and illegal distribution, and personal and property offenses. OIG investigative and Hotline work resulted in 1,123 administrative sanctions and corrective actions. Our staff, at all levels and across each directorate, has played an integral role in providing effective oversight work that reflects our mission, vision, and values. I am grateful for their efforts and thankful for the support of our Nation’s veterans, Congress, Veteran Service Organizations, and stakeholders. We look forward to working with dedicated VA leaders and staff to foster a culture of continuous improvement for the benefit of veterans and their families. MICHAEL J. MISSAL Inspector General 2 | VA Office of Inspector General Issue 78 | April 1–September 30, 2017 Highlights of VA OIG Activities Pursuant to Public Law (P.L.) 95-452, Inspector General Act of 1978, as amended, this Report presents our accomplishments during the reporting period April 1–September 30, 2017. Highlighted below are some of the activities conducted during this reporting period and their impact. Office of Investigations Th e Offi ce of Investigations continues to coordinate with other law enforcement agencies to identify a wide range of criminal activity. Among notable cases were these regarding serious allegations of fraud. A VA OIG, Housing and Urban Development OIG, and Federal Housing Administration (FHA) OIG investigation determined that a mortgage company failed to comply with certain VA, Fannie Mae, Freddie Mac, and FHA origination, underwriting, and quality control requirements. Th e mortgage company and its subsidiaries agreed to pay the United States $74,453,802 to resolve allegations that they violated the False Claims Act by knowingly originating and underwriting mortgage loans insured, guaranteed, and purchased by Government programs that did not meet applicable requirements. Th e VA portion of the settlement was $6,464,000. A nationwide VA OIG, Federal Bureau of Investigation, and Department of Justice OIG investigation resulted in charges that alleged between 2011 and 2015 the defendant, the school’s president, the school’s former vice president, and veterans conspired to defraud VA of more than $4.3 million in education benefi ts. Th e school received infl ated, unearned tuition and fees ranging between $5,000 and $13,000 per course, while the veterans received basic housing allowance and a books and supplies stipend totaling over $2,000 per month. Th e former student coordinator of a trucking school pled guilty to wire fraud for his part in enrolling at least 108 veterans who allegedly never attended or received training at the school. OIG investigators completed nearly 300 investigations and made more than 160 arrests for fraud, bribery, embezzlement, identity theft , drug crimes, and personal and property crimes. More than 1,000 administrative sanctions and corrective actions were taken as a result of investigations. Office of Healthcare Inspections OHI published 77 reports that range from reviews of the performance and eff ectiveness of leadership at individual VA hospitals, to reviews of national VA Suicide programs and to the evaluation of single veterans treated at VA hospitals. OHI continues to focus and report on VA’s eff orts to improve Veterans Health Administration’s (VHA’s) opioid prescribing practices and delivery of mental health (MH) services to veterans. Below are some examples of our reports in these critically important areas: • In Healthcare Inspection – Review of Opioid Prescribing Practices, Clement J. Zablocki VAMC, Milwaukee, Wisconsin, OHI reviewed the prescribing practices related to controlled substances at the Clement J. Zablocki VAMC, Milwaukee, WI and made recommendations to improve oversight of narcotic prescribing practices to ensure providers employ the most appropriate treatments for veterans with chronic pain. • In Healthcare Inspection – Opioid Prescribing to High-Risk Veterans Receiving VA Purchased Care, OHI identifi ed that non-VA providers were not required to adhere to Opioid Safety Initiative guidelines
Recommended publications
  • In. ^Ifil Fiegree in PNILOSOPNY
    ISLAMIC PHILOSOPHY OF SCIENCE: A CRITICAL STUDY O F HOSSAIN NASR Dis««rtation Submitted TO THE Aiigarh Muslim University, Aligarh for the a^ar d of in. ^Ifil fiegree IN PNILOSOPNY BY SHBIKH ARJBD Abl Under the Kind Supervision of PROF. S. WAHEED AKHTAR Cbiimwa, D«ptt. ol PhiloMphy. DEPARTMENT OF PHILOSOPHY ALIGARH IWIUSLIIM UNIVERSITY ALIGARH 1993 nmiH DS2464 gg®g@eg^^@@@g@@€'@@@@gl| " 0 3 9 H ^ ? S f I O ( D .'^ ••• ¥4 H ,. f f 3« K &^: 3 * 9 m H m «< K t c * - ft .1 D i f m e Q > i j 8"' r E > H I > 5 C I- 115m Vi\ ?- 2 S? 1 i' C £ O H Tl < ACKNOWLEDGEMENT In the name of Allah« the Merciful and the Compassionate. It gives me great pleasure to thanks my kind hearted supervisor Prof. S. Waheed Akhtar, Chairman, Department of Philosophy, who guided me to complete this work. In spite of his multifarious intellectual activities, he gave me valuable time and encouraged me from time to time for this work. Not only he is a philosopher but also a man of literature and sugge'sted me such kind of topic. Without his careful guidance this work could not be completed in proper time. I am indebted to my parents, SK Samser All and Mrs. AJema Khatun and also thankful to my uncle Dr. Sheikh Amjad Ali for encouraging me in research. I am also thankful to my teachers in the department of Philosophy, Dr. M. Rafique, Dr. Tasaduque Hussain, Mr. Naushad, Mr. Muquim and Dr. Sayed.
    [Show full text]
  • Intensive Care Units (ICU): the Clinical Pharmacist Role to Improve Clinical Outcomes and Reduce Mortality Rate- an Undeniable Function
    Open Access Journal of Clinical Intensive Care and Medicine Review Article Intensive Care Units (ICU): The clinical pharmacist role to improve clinical ISSN 2639-6653 outcomes and reduce mortality rate- An undeniable function Luisetto M1* and Ghulam Rasool Mashori2 1Applied Pharmacologist, Hospital Pharmacist Manager 29121, Italy 2Professor & Director, Peoples University of Medcial & Health Sciences for Woman, Nawabshah, Pakistan *Address for Correspondence: Luisetto M, Applied Abstract Pharmacologist, Hospital Pharmacist Manager 29121, Italy, Email: [email protected] Observing relevant biomedical literature we have see that clinical pharmacist play a crucial role in ICU Submitted: 09 October 2017 settings with reducing in mortality rate and improving some clinical outcomes. Approved: 01 November 2017 Published: 02 November 2017 Copyright: 2017 Luisetto M, et al. This is Introduction an open access article distributed under the Creative Commons Attribution License, which In ICU settings we can easily observe that the mortality rate is higher then other permits unrestricted use, distribution, and wards and for this reason a real multisiciplinatity medical team with added clinical ph. reproduction in any medium, provided the Competences can improve this situation. High intensity of cure, polipharmacy, critical original work is properly cited. patient conditions need also a pharmaceutical competencies to be added to the classic Keywords: ICU; Clinical pharmacy; Pharmaceutical decision making systems (clinical- managerial). The critically hill patients need a more care; Clinical outcomes; Mortality rate rational decision making systems to improve the clinical outcomes and in safety way. Material and Methods In this review and research paper we have searched some relevant biomedical literature in order to evaluate the real eficacy of clinical pharmacist in improving clinical outcomes and reducing mortality rate.
    [Show full text]
  • Introduction to Hospital and Health-System Pharmacy Practice 59 Tients with a Specific Disease State Or for Activities Related to Self Governance Diagnosis
    Part II: Managing Medication Use CHAPTER 4 Medication Management Kathy A. Chase ■■ ■■■ Key Terms and Definitions Learning Objectives ■■ Closed formulary: A list of medica- After completing this chapter, readers tions (formulary) which limits access should be able to: of a practitioner to some medications. 1. Describe the purpose of a formulary A closed formulary may limit drugs to system in managing medication use in specific physicians, patient care areas, or institutions. disease states via formulary restrictions. 2. Discuss the organization and role of the ■■ Drug formulary: A formulary is a pharmacy and therapeutics committee. continually updated list of medications 3. Explain how formulary management and related information, representing works. the clinical judgment of pharmacists, 4. List the principles of a sound formulary physicians, and other experts in the system. diagnosis and/or treatment of disease 5. Define key terms in formulary manage- and promotion of health. ment. ■■ Drug monograph: A written, unbi- ased evaluation of a specific medica- tion. This document includes the drug name, therapeutic class, pharmacology, indications for use, summary of clinical trials, pharmacokinetics/dynamics, ad- verse effects, drug interactions, dosage regimens, and cost. ■■ Drug therapy guidelines: A document describing the indications, dosage regi- mens, duration of therapy, mode(s) of administration, monitoring parameters and special considerations for use of a specific medication or medication class. ■■ Drug use evaluation (DUE): A process used to assess the appropriate- ness of drug therapy by engaging in the evaluation of data on drug use in a given health care environment against predetermined criteria and standards. ◆■ Diagnosis-related DUE: A drug use evaluation completed on pa- INTRODUCTION TO HOSPITAL AND HEALTH-SYSTEM PHARMACY PRACTICE 59 tients with a specific disease state or for activities related to self governance diagnosis.
    [Show full text]
  • Download Download
    Original Research PRACTICE-BASED RESEARCH Descriptive Analysis of Acceptance by Prescribers and Economic Benefit of Pharmacist Recommended Interventions in a Critical Care Unit YoonJung Lee, PharmD1, 2; Lana Gettman, PharmD2 1Texas Tech University Health Sciences Center; 2Harding University College of Pharmacy ABSTRACT Background: Pharmacist clinical intervention is defined as the action that identifies and prevents medication-related problems and optimizes patient’s medication therapy in cooperation with other healthcare professionals. Types of clinical interventions may vary, but each is patient specific. Few studies have focused on clinical pharmacists interventions in a critical care setting at a rural hospital. Objectives: The purpose of this study was to assess physician acceptance rate of pharmacist-recommended interventions in the critical care unit (CCU) at a rural hospital over five years and to evaluate the economic benefit of accepted pharmacist-recommended interventions over a one-year time period. Methods: This study was a retrospective chart review over a five-year time period. Each intervention was categorized and analyzed for acceptance or non-acceptance by the treating physician. Evaluation of economic benefit, cost saving and cost avoidance, for a one-year time period was performed. Results: A total of 1275 interventions were documented during study period. The average acceptance rate for documented interventions was 56%. The acceptance rate by physicians increased over the study period; with the acceptance rate in 2013 being statistically significantly higher than any other years. The overall cost saving for selected interventions was $432 for the one year. The overall cost avoidance of all accepted interventions for the one year was $453,339.36-$468,327.62.
    [Show full text]
  • Gap Analysis Between Patients' Expectations and Services
    JRFHHA Gap Analysis between Patients’ Expectations and Services Provided by Pharmacy10.5005/jp-journals-10035-1018 Store of a Tertiary Care Hospital RESEARCH ARTICLE Gap Analysis between Patients’ Expectations and Services Provided by Pharmacy Store of a Tertiary Care Hospital 1Jharna Bajpai, 2Nirmal K Gurbani ABSTRACT INTRODUCTION Pharmacy store of hospital is among one the major revenue In recent years, awareness has risen on how patients perceive generating area of hospital. Its performance can be a vital the quality of their healthcare. Consequently measuring element in the success of any upcoming hospital. Nowadays, not only the availability of prescribed drugs matters but explanation patient satisfaction has become an important tool to gain of dose, frequency and duration of drugs to be taken, behavior of attention and value among the healthcare consumers as well pharmacist and waiting time to get drugs play an important role as competitors. Measuring patient satisfaction encompasses in satisfaction of patients. The pharmacy store of the hospital evaluating patient’s perceptions and determining whether provides more specialized and more time-saving services they felt that their needs met.1 Research in the area of ‘Hospital for patients. It also eases the financial burden on pharmacy users via drug discounts. A cross-sectional comparative study Administration in India’ is still in its infant stage. To men- was conducted on 90 respondents. A self administered pre- tion a few important research works carried out in India, designed, pretested, structured questionnaire was given to a reference can be made to Sreenivas2 who examined why selected respondents on first contact to the pharmacy store the hospital administrator should take patient-satisfaction of the hospital with the aim to study the perception of patients seriously as a measurement.
    [Show full text]
  • Integrating the Healthcare Enterprise Hospital Pharmacy and Community Pharmacy Use Cases and Standards White Paper Final Text Ve
    Hospital Pharmacy and Community Pharmacy – Use Cases and Standards – v1.2 Integrating the Healthcare Enterprise Hospital Pharmacy and Community Pharmacy Use Cases and Standards White Paper Final Text Version 1.2 1 / 70 Copyright © 2010, IHE Europe Hospital Pharmacy and Community Pharmacy – Use Cases and Standards – v1.2 Document version Editor Remarks 1.2 N. Canu, PHAST Final Text G. Claeys, Agfa Healthcare T. de Jong, HL7 A. Estelrich, GIP/DMP I. Gibaud, SIB S. Juvin, GIP/DMP F. Macary, GMSIH V. Mary, SIB J. Nuñez Suarez, INDRA C. Rica, GIP/DMP A. Slee, NHS M. Sprenger, NICTIZ J. Surugue, EAHP S. Thun, DIMDI L. Tzimis, EAHP 2 / 70 Copyright © 2010, IHE Europe Hospital Pharmacy and Community Pharmacy – Use Cases and Standards – v1.2 Contents _____________________________________________________________________________________ 3 / 70 Copyright © 2010, IHE Europe 1 Introduction The Pharmacy domain is increasingly adopting Information & Communication Technologies to support their main activities like prescription and medication dispense. In order to guarantee interoperability among the different ICT systems in the Pharmacy domain, it is important that all stakeholders (users, vendors, payers) agree on a set of common communication standards. The purpose of this White Paper is to identify the critical interoperability needs in the Pharmacy domain, describe the corresponding interoperability Use Cases and propose a set of communication standards to implement these Use Cases. The White Paper can serve as basis for the development of one or more IHE Pharmacy Integration Profiles. The document starts with an overview of the main business processes in the pharmacy domain, describing the workflow and the information flows. These business processes are the basis for describing the various Interoperability Use Cases.
    [Show full text]
  • Program and Exhibition Guide
    PROGRAM AND EXHIBITION GUIDE s January 17-21, 2015 s Phoenix Convention Center s Phoenix, Arizona, USA Download the Congress App The Root of Better Care Please visit Masimo Booth #1007 Root® is an intuitive patient monitoring and connectivity platform designed to transform patient care from the operating theater to the general ward through a powerful combination of the following high-impact innovations: > Radical-7® Instant interpretation of Masimo’s breakthrough rainbow® and SET® measurements via Root’s intuitive navigation and high-visibility, touchscreen display > MOC-9™ Flexible measurement expansion through Masimo Open Connect™ (MOC-9)—with SedLine® brain function monitoring, Phasein™ capnography, and the ability to expand with additional third-party measurements > Iris™ Built-in connectivity gateway for standalone devices such as IV pumps, ventilators, hospital beds, and other patient monitors See for yourself how Root is destined to transform patient care at www.masimo.com/root 877.4.MASIMO | www.masimo.com Root is CE Marked. © 2014 Masimo. All rights reserved. For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events. 8655A_Ad_Root_Sedline_SCCM_2015_8.5x11.indd 1 11/12/14 4:45 PM s February 20-24, 2016 s Orange County Convention Center s Orlando, Florida, USA Inspiration at Work Connect with colleagues, experience leading-edge innovations in critical care medicine, and stretch your imagination at the Society of Critical Care Medicine’s (SCCM) 45th Critical Care Congress. Inspiration is the driving force behind a successful Congress and the spark that ignites the imagination. Participants will be certain to leave Orlando refreshed and inspired after this unparalleled event.
    [Show full text]
  • EAHP Survey 2010 on Hospital Pharmacy in Europe
    BMJ 2139 European Journal of Hospital Pharmacy EAHP_European Journal of Hospital Pharmacy EAHP 05/06/2013 13:24 Page 1 HoEuropeasn Jouprnal ofital Pharmacy SCIENCE AND PRACTICE EAHP SURVEY 2010 Hospital Pharmacy Practice in Europe ejhp.bmj.com EAHP Survey 2010 on hospital pharmacy in Europe Dr. Roberto Frontini, EAHP President Since 1995, every five years the European Association of Hospital Pharma- cists (EAHP) has compiled and published a comprehensive survey of hospital pharmacy practice across Europe. The fourth survey was conducted in 2010, with data collected until January 2011. It is a pleasure for me to present in this booklet a summary of the results, which were published in a series in the EAHP’s official journal, European Journal of Hospital Pharmacy: Science and Practice (EJHP), in 2012 and 2013. The survey data are not presented question by question but rather are the- matically grouped into five chapters that encompass the spread of hospital pharmacy activity: 1. General frame and staffing; 2. Procurement and distribution; 3. Production and quality assurance; 4. Clinical services and patient safety; and, 5. Education and research In this way we hope to give a more concise overview without making concessions on the provision of detailed information by coun- try, by type, and by size of hospital. Where sensible and according to the quality of the data gathered, we also make some compari- sons to the results of the 2005 and 2000 surveys. Whilst the scale of difference in questions asked in the first EAHP survey (1995) is too high to allow comparisons with the 2010 data, it is still possible to track the developments in hospital pharmacy practice over the last decade.
    [Show full text]
  • HOSPITAL PHARMACY OPERATIONS REPORT Introduction
    2020 HPORHOSPITAL PHARMACY OPERATIONS REPORT Introduction At Kit Check, we believe that tomorrow’s innovations come from thoroughly understanding the challenges of today. This solution-oriented model has helped our network of more than 700 hospitals achieve success through operational efficiency, patient safety, and medication visibility. We weren’t satisfied with turning to our own experiences and perspectives for answers, so we developed our proprietary annual survey to derive key insights and intelligence from pharmacy decision-makers. We think of the Hospital Pharmacy Operations Report survey as our road map forward—shedding light on the state of the industry to inform and equip leaders for what’s to come. Now entering its 7th consecutive year, the 2020 Hospital Pharmacy Operations Report (HPOR) once again takes us inside the minds of Hospital Pharmacy leaders. We’ll hear firsthand from those on the front lines of a global pandemic about how they experienced an unprecedented and unexpected year. We’ll learn how COVID-19 has challenged workflows, shifted priorities, and reshaped the future of the hospital pharmacy industry. In a year that stress-tested the entire drug supply chain, we’ll understand why pharmacy leaders are turning to new technologies to future-proof their operations. THE 2020 HOSPITAL PHARMACY OPERATIONS REPORT 2 Contents Key Themes………………………04 Methodology……………….……..05 Drug Shortages ……………….…07 Drug Recalls …………….…….…08 Staffing Challenges……..…….…09 New Tech Initiatives…………......10 Tightening Budgets……..……..…12 Inventory Visibility……………..…13 Dispense Approaches….……..…15 Medication Intelligence…….……16 Drug Diversions…………....….…18 DSCSA 2023 Regulations …...…22 THE 2020 HOSPITAL PHARMACY OPERATIONS REPORT 3 Key Themes THEME 1 THEME 2 Future Operational Proofing Efficiency After a global pandemic Facing tight budgets & limited stress-tested the entire staff hours, pharmacy industry, pharmacy leaders systems are focused on are looking ahead and optimizing their workflows.
    [Show full text]
  • Department of Public Health 105 Cmr 722.000
    105 CMR: DEPARTMENT OF PUBLIC HEALTH 105 CMR 722.000: DISPENSING PROCEDURES FOR CLINIC AND HOSPITAL PHARMACIES Section 722.001: Purpose 722.020: Definitions 722.090: Hospital Pharmacies 722.091: Clinic Pharmacies 722.095: Waivers 722.100: Severability 722.001: Purpose The purpose of 105 CMR 722.001 is to describe procedures which clinic and hospital pharmacies must follow when dispensing drug products in accordance with M.G.L. c. 94C. 722.020: Definitions The terms used in 105 CMR 722.000 have the following meanings. Terms defined in M.G.L. c. 112, § 12D and c. 94C, § 1, and not defined in 105 CMR 722.000 shall have the meanings set forth therein when used in 105 CMR 722.000, unless the context clearly requires a different interpretation. Clinic. An entity licensed by the Department of Public Health as a clinic, as defined in M.G.L. c. 111, § 52. Clinic Employee. Persons currently on payroll or medical staff members of the clinic, system or accountable care organization, and their spouses and dependents living in the same household; clinic volunteers; students working at the clinic, or individuals contracted for employment by the clinic, system or accountable care organization. Clinic Patient. A person formally registered as a patient who is receiving services or treatment at the clinic. Clinic Pharmacy. A pharmacy that is not registered as a retail drug business pursuant to M.G.L. c. 112, § 39 and which is maintained and operated by the clinic. Commissioner. The Commissioner of the Massachusetts Department of Public Health. Discharge Patient. For the purpose of 105 CMR 722.000 only, a discharge patient is a person who has been released from an inpatient hospital bed and is no longer registered as a hospital patient.
    [Show full text]
  • Primary and Secondary Care Systems
    16_1428PP_CH12.qxd 14/10/05 4:46 pm Page 177 12 Primary and secondary care systems Introduction The use of IT in both the primary and the secondary care sectors of phar- macy has until recently centred on the supply function of pharmacists, and as such is not clinically based. Although both hospital and commu- nity pharmacy systems have the facility to record information on the patient’s medication record, this is only a byproduct of the dispensing process, i.e. the supply function. In hospitals, the supply of drugs is very different from that in the community. Many drugs in hospital are supplied in bulk to the ward rather than on an individual basis, as is the case in community pharmacy. This difference is reflected in the fact that the IT systems used in hospitals are generally not the same as those used in com- munity pharmacies. The role of pharmacists in both primary and sec- ondary care is changing and becoming more clinically oriented and focused. To carry out this role pharmacists require access to a patient’s medical history and laboratory results. Much of this information is avail- able in the paper notes or in many disparate computer systems, but can be time-consuming to obtain and requires access to GP systems and notes. One of the government’s key programmes is the National Programme for Information Technology (NPfIT) (www.npfit.nhs.uk), which consists of many separate projects and will enable new ways of working by utilising the benefits of IT. The programme has been rebranded as Connecting for Health (www.connectingforhealth.nhs.uk).
    [Show full text]
  • Clinical Placement of Saudi Intern Pharmacists at Coronary Care Unit
    Quest Journals Journal of Research in Pharmaceutical Science Volume 2 ~ Issue 10 (2015) pp: 04-07 ISSN(Online) : 2347-2995 www.questjournals.org Research Paper Clinical Placement of Saudi Intern Pharmacists at Coronary Care Unit Mohamed Hassan Elnaem1 Department of Pharmacy Practice, Kulliyyah of Pharmacy, international Islamic University Malaysia. Received 21 September, 2015; Accepted 10 October, 2015 © The author(s) 2014. Published with open access at www.questjournals.org ABSTRACT:- Introduction: The first batch of pharmacy students at Jazan University start their internship year and it is important to hear from interns about their opinion regarding internship year's clinical placements.The study tries to explore intern pharmacists’ perceptions and opinions about their clinical placement at coronary care unit of King Fahd Central Hospital, Jazan, Saudi Arabia. Materials and methods: one questionnaire consists of 10 items was sent to all intern pharmacists of college of pharmacy- Jazan University who trained for 1 month at coronary care unit of king Fahd central hospital as a part of their internship year training program Results: A majority of responses (86%) rate the internship year as extremely important in shaping their future career. All the received responses describe transition from classroom-based education to initial clinical placement at coronary care unit as difficult. Many responses (60%) do not know any cardiology clinical pharmacy knowledge resources. Finally, intern pharmacists perceive smart phone application as the best design for a cardiology clinical pharmacy knowledge resource. Conclusions: Saudi intern pharmacists involved in our study are able to realize the importance of their internship year in shaping their future professional career and express their need for clinical knowledge support tools in their coronary care rotation which is preferred to be designed as smart phone applications because of availability, easy use and accessibility.
    [Show full text]